Chemosensitization is not associated with improved adjuvant radiation outcomes for cutaneous squamous cell carcinoma: A dual-center retrospective cohort study - 18/12/25
Doi : 10.1016/j.jaad.2025.09.015
Emily E. Granger, MD a, Emily Y. Kim, MD b, Nina A. Ran, MD, MS, MPH c, Karina Brito, BS d, David M. Wang, MD, MPH c, Ann W. Silk, MD d, Danielle N. Margalit, MD e, Roy B. Tishler, MD e, Jonathan D. Schoenfeld, MD, MPH e, Shauna Campbell, DO f, Allison Vidimos, MD g, Daniel McGrail, PhD h, Shlomo Koyfman, MD f, Emily S. Ruiz, MD, MPH c, ⁎ 
a Department of Dermatology, Duke University, Durham, North Carolina
b Department of Dermatology, University of Michigan Hospital, Ann Arbor, Michigan
c Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts
d Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
e Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts
f Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio
g Department of Dermatology, Cleveland Clinic, Cleveland, Ohio
h Center for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio
∗ Correspondence to: Emily S. Ruiz, MD, MPH, Department of Dermatology, Brigham and Women's Hospital, 1153 Centre St, Suite 4J, Boston, MA 02130 Department of Dermatology Brigham and Women's Hospital 1153 Centre St Suite 4J Boston MA 02130
Key words : adjuvant radiation therapy, chemoradiation, cutaneous oncology, cutaneous squamous cell carcinoma, nonmelanoma skin cancer, systemic therapy
Mappa
| Drs Granger, Kim, Koyfman, and Ruiz contributed equally. |
|
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Reviewed and approved by institutional review boards at Brigham and Women's Hospital/Dana-Farber Cancer Institute (IRB:2018P002653) and Cleveland Clinic Foundation (IRB:17-123). |
© 2025
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 94 - N° 1
P. 284-287 - gennaio 2026 Ritorno al numero
Articolo precedente
- Risk of cutaneous T-cell lymphoma in patients with autoimmune diseases
- Bethany Brumbaugh, Mike Westmeijer, Beatrix Thompson, Allison Holt, Joseph Ebriani, Kevin Sheng-Kai Ma, Steven T. Chen
- Diagnostic accuracy of ChatGPT in dermatology: A meta-analysis of textual versus visual prompts
- Ryan Chen, Daniel H. Nguyen, Kevin D. Fettel, William J. Nahm, Goranit Sakunchotpanit, Sarah S. Lee, Krithika Nayudu, Vinod E. Nambudiri
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?